🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 14 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/05/2006 37,38 38,58 36,96 37,74 +0,96% 4,33% 139.017
03/05/2006 38,04 38,16 36,90 37,38 -1,11% 3,31% 151.217
02/05/2006 38,46 38,88 37,20 37,80 -1,56% 4,37% 138.617
01/05/2006 38,10 39,18 37,68 38,40 +0,63% 3,94% 260.700
28/04/2006 38,58 39,90 38,04 38,16 -0,63% 4,82% 116.783
27/04/2006 37,32 38,82 36,66 38,40 +2,24% 5,79% 172.750
26/04/2006 39,18 39,42 37,50 37,56 -4,72% 4,90% 200.200
25/04/2006 39,90 40,50 39,00 39,42 -1,35% 3,76% 120.550
24/04/2006 40,98 41,40 39,60 39,96 -1,62% 4,39% 236.117
21/04/2006 36,54 41,34 36,54 40,62 +11,17% 13,14% 523.233
20/04/2006 37,80 38,10 36,30 36,54 -4,40% 4,76% 309.367
19/04/2006 39,72 40,08 36,96 38,22 -3,78% 7,85% 512.550
18/04/2006 40,32 40,80 39,06 39,72 -1,19% 4,32% 201.900
17/04/2006 40,38 41,46 39,54 40,20 -2,47% 4,75% 200.900
13/04/2006 41,16 42,00 40,68 41,22 -0,29% 3,21% 113.350
12/04/2006 40,50 41,70 40,14 41,34 +1,62% 3,85% 129.400
11/04/2006 41,46 41,82 39,90 40,68 -2,16% 4,63% 469.333
10/04/2006 42,24 42,84 39,30 41,58 -1,70% 8,38% 504.250
07/04/2006 43,50 44,04 41,46 42,30 -2,49% 5,93% 345.067
06/04/2006 43,08 44,16 42,12 43,38 +1,97% 4,74% 229.833
05/04/2006 43,20 43,68 40,56 42,54 -1,94% 7,22% 311.433
04/04/2006 45,06 45,60 42,60 43,38 -4,24% 6,66% 375.067
03/04/2006 46,80 46,92 44,88 45,30 -0,53% 4,36% 379.850
31/03/2006 45,54 46,74 43,56 45,54 -0,52% 6,98% 739.617
30/03/2006 42,48 46,80 42,42 45,78 +15,78% 10,31% 2.023.350
29/03/2006 38,88 40,02 38,46 39,54 +1,70% 4,01% 150.200
28/03/2006 38,94 39,54 37,80 38,88 -0,15% 4,47% 133.333
27/03/2006 39,84 40,74 38,58 38,94 -2,41% 5,42% 143.217
24/03/2006 41,04 41,04 39,30 39,90 -2,21% 4,24% 183.717
23/03/2006 41,04 41,64 40,20 40,80 -2,58% 3,51% 153.283